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IMPROVING ACTIVITIES OF DAILY LIVING ABILITY IN WOMEN WITH FIBROMYALGIA: 
AN EXPLORATORY, QUASI-RANDOMIZED, PHASE-TWO STUDY, IMPROvE TRIAL
Cecilie VON BÜLOW, MSc, OT, PhD1,2,3, Kirstine AMRIS, MD1, Elisabeth BANDAK, MSC, PT, PhD-Student1, Bente 
DANNESKIOLD-SAMSØE MD, DMSc1 and Eva EJLERSEN WÆHRENS, MSc, OT, PhD1,2
1From the Parker Institute, Copenhagen University Hospital, Bispebjerg-Frederiksberg Hospital, 2The Research Initiative for Activity 
Studies and Occupational Therapy, General Practice, Department of Public Health, University of Southern Denmark, Odense and 
3Metropolitan University College, Copenhagen, Denmark
Objective: To explore and compare the outcomes of 
adaptation and physical activity programmes regar-
ding activities of daily living (ADL) ability following 
LQWHUGLVFLSOLQDU\UHKDELOLWDWLRQLQZRPHQZLWK¿EUR-
myalgia. 
Methods: Participants (n = 85) were quasi-randomi-
zed to 16-week adaptation (ADAPT) or physical ac-
tivity (ACTIVE) programmes following 2-week inter-
disciplinary rehabilitation. Primary outcomes were 
ADL motor and ADL process ability, measured with 
the Assessment of Motor and Process Skills (AMPS) 
at 4-week follow-up. Data were analysed per pro-
tocol.
Results: Participants (ADAPT, n = 21; ACTIVE, n = 27) 
did not differ from withdrawers (n = 37). Improve-
ments in ADL ability in the ADAPT (ADL motor mean 
FKDQJH ORJLWVFRQ¿GHQFHLQWHUYDO
CI) = 0.31–0.56); ADL process mean change = 0.34 
logits (95% CI = 0.17–0.52)) and ACTIVE (ADL 
motor mean change = 0.33 logits (95% CI = 0.22–
0.43); ADL process mean change = 0.25 logits (95% 
&, ± JURXSV ZHUH VWDWLVWLFDOO\ VLJQL¿-
cant, with no differences between groups. Respon-
der analyses revealed that 63% of all participants 
obtained clinically relevant improvements in ADL 
motor ability and 48% in ADL process ability.
Conclusion: Although limited by a large drop-out, 
this exploratory study showed that both adaptation 
and physical activity programmes following interdis-
ciplinary rehabilitation improved ADL ability in the 
majority of participants. ADL ability outcomes were 
independent of group allocation (ADAPT vs ACTIVE), 
VXJJHVWLQJHI¿FDF\RIERWKSURJUDPPHV
Key words: occupational therapy; physiotherapy; Assess-
ment of Motor and Process Skills; ADL; intervention; reha-
bilitation.
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Improved functioning is a main goal of rehabilita-tion (1, 2). Essential to functioning is the ability to 
perform activities of daily living (ADL), such as self-
care and household tasks (1, 2). ADL ability in women 
ZLWK¿EURP\DOJLDHQFRXQWHUHGLQWHUWLDU\FDUHKDVEHHQ
VKRZQWREHVLJQL¿FDQWO\UHGXFHGDQGWKHH[WHQWRI
ADL task performance problems often cause these in-
dividuals to need assistance for safe community living 
(3). Multidisciplinary and interdisciplinary rehabilita-
tion is recommended (4, 5), but despite clinically rele-
vant improvements in ADL ability after rehabilitation, 
ZRPHQZLWK¿EURP\DOJLDVWLOOVKRZFRQVLGHUDEOH$'/
disability and large inter-individual patient variability 
in functional gains (6). It has therefore been suggested 
that clinical effectiveness may be promoted if inter-
vention programmes are more individually tailored 
DQGVSHFL¿FDOO\GHVLJQHGWRLPSURYH$'/DELOLW\
([HUFLVHHJDHURELFVWUHQJWKDQGÀH[LELOLW\WUDLQ-
ing) and physical activity (e.g. recreational physical 
activity, sports and brisk walking) are recommended 
LQWKHPDQDJHPHQWRI¿EURP\DOJLDWRLPSURYHIXQFWLR-
ning, including ADL ability (7, 8). Studies, however, 
report problems related to adherence, adverse events 
and high drop-out rates (7, 8) and severely impacted 
persons seem to gain less effect (9). Thus, while some 
EHQH¿W IURP H[HUFLVHSK\VLFDO DFWLYLW\ RWKHUVPD\
need other types of intervention to improve ADL 
ability.
Interventions focusing on adaptation emphasize 
helping persons to adapt to situations and change the 
environment, rather than focusing on restoration of 
body functions and structures (10, 11). Adaptation 
includes the use of strategies to compensate for per-
formance problems, such as changing routines, using 
DVVLVWLYHGHYLFHVDQGPRGLI\LQJWDVNVDQGSK\VLFDO
social environments (12). Adaptation is not associated 
with adverse events (5) and has been shown to improve 
ADL ability in populations with various chronic health 
conditions (13, 14). Adaptation is also recommended 
DVSDUWRIUHKDELOLWDWLRQIRUSHRSOHZLWK¿EURP\DOJLD
DOWKRXJKHYLGHQFHVXSSRUWLQJ LWVHI¿FDF\ LV
lacking. 
7KXVWKHDLPRIWKLVH[SORUDWRU\VWXG\ZDVWRLQ-
vestigate changes in ADL ability and to compare ADL 
ability outcomes of adaptation and physical activity 
programmes following a 2-week interdisciplinary re-
KDELOLWDWLRQSURJUDPPHLQZRPHQZLWK¿EURP\DOJLD
$VH[HUFLVHSK\VLFDODFWLYLW\VHHPVWREHHIIHFWLYHLQ
VRPHLQGLYLGXDOVZLWK¿EURP\DOJLD±RWKHUVPLJKW
EHQH¿W IURP DGDSWDWLRQ ,WZDV WKHUHIRUH DVVXPHG
that both programmes would enhance ADL ability 
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242 C. von Bülow et al.
outcomes and that no programme would be superior 
to the other. 
METHODS
Study design and participants 
7KLVH[SORUDWRU\TXDVLUDQGRPL]HGVWXG\ZDVFRQGXFWHGIURP
January 2012 to February 2013. The study constituted the second 
phase of the IMPROvE study (Interdisciplinary Rehabilitation 
of Patients with Chronic Widespread Pain: Primary Endpoint 
of the Randomised, Non-Blinded, Parallel-Group IMPROvE 
Trial) (6), approved by the local ethics committee of the Capital 
Region of Denmark (H-2-2010-139), carried out in accordance 
with principles of the Declaration of Helsinki and registered 
with www.clinicaltrials.gov, number NCT01352052. While 
SKDVH,,0352Y(LQYHVWLJHGRXWFRPHVRIDZHHNLQWHU-
GLVFLSOLQDU\UHKDELOLWDWLRQSURJUDPPHWKLVSKDVH,,,0352Y(
H[SORUHGRXWFRPHVRIWKHVDPHZHHNLQWHUGLVFLSOLQDU\UHKDEL-
litation programme followed by additional 16-week adaptation 
or physical activity programmes (Fig. 1). Participants in the 
IMPROvE study were recruited from the outpatient clinic at 
the Department of Rheumatology, Bispebjerg-Frederiksberg 
Hospital, Denmark; all women, > \HDUVRIDJHDQGIXO¿OOHG
WKH$PHULFDQ&ROOHJHRI5KHXPDWRORJ\$&5FODVVL¿FD-
WLRQFULWHULDIRU¿EURP\DOJLD
Quasi-randomization and blinding
3DUWLFLSDQWV DFWLQJ DVZDLWLQJ OLVW FRQWURO JURXS LQ SKDVH ,
IMPROvE were consecutively enrolled in the interdisciplinary 
rehabilitation programme in groups of 8. Groups (n = 12) were 
WKHQTXDVLUDQGRPL]HGE\FRLQÀLSE\DELRVWDWLVWLFLDQZKRZDV
not involved in the study. Odd-numbered groups (i.e. 1, 3, 5, 7, 
9, 11) were allocated to the adaptation programme (ADAPT) 
and even-numbered groups (i.e. 2, 4, 6, 8, 10, 12) to the phy-
sical activity programme (ACTIVE). Neither staff involved in 
the interdisciplinary rehabilitation programme nor participants 
were informed about group allocation until the last day of the 
interdisciplinary rehabilitation programme, where the therapists 
conducting the ADAPT and ACTIVE programmes revealed the 
allocation. Assessments were performed by blinded assessors 
not informed about the participants’ allocation and not involved 
in the ADAPT and ACTIVE programmes. Questionnaires were 
completed using touch screens, which have been shown to give 
comparable results to answers given on paper (17).
Interdisciplinary rehabilitation programme
The interdisciplinary rehabilitation was a 2-week outpatient, 
group-based programme conducted by a rheumatologist, psy-
chologist, nurse, and occupational and physical therapists. The 
programme had a daily time schedule between 3 and 5 h and 
included a team conference aiming at monitoring individuals’ 
progression towards overall rehabilitation goals, i.e. increasing 
functional ability and coping with pain (6). 
ADAPT and ACTIVE programmes 
The ADAPT and ACTIVE programmes were developed to in-
vestigate whether adaptation and physical activity programmes 
provided as an add-on would enhance ADL ability outcomes in 
ZRPHQZLWK¿EURP\DOJLD%RWKSURJUDPPHVODVWHGZHHNV
ZHUHJURXSEDVHGDQGLQVSLUHGE\DQH[LVWLQJSURJUDPPH
VXSSRUWLQJHGXFDWLRQUHÀHFWLRQEUDLQVWRUPVJURXSGLVFXVVLRQV
DQGSHHUH[FKDQJHDVDPHDQVWRSURPRWHFKDQJHVLQHYHU\GD\
life. Sessions typically began with a short lecture or a discus-
VLRQ LQLWLDWHG E\ WKH WKHUDSLVW SRVLQJ D TXHVWLRQ2YHU WLPH
WKHSDUWLFLSDQWVZHUHWRDVVXPHWKHUROHRIH[SHUWVDQGVKDUH
NQRZOHGJHIURPWKHLURZQH[SHULHQFHV7KHSURJUDPPHVZHUH
SULPDULO\HGXFDWLRQEDVHGDQGWRDOHVVHUH[WHQWHQFRPSDVVHG
SUDFWLFDOH[HUFLVHV3DUWLFLSDQWVZHUHHQFRXUDJHGWRLPSOHPHQW
adaptation strategies or increase the level of physical activity 
at home in-between sessions. 
ADAPT programme. 7KH$'$37SURJUDPPH $SSHQGL[ ,
was developed and led by an occupational therapist, included 
16 2-h sessions and aimed at improving ADL ability by means 
RIDGDSWDWLRQ±7KLVDSSURDFKZDVEDVHGRQWKHDVVXPS-
tion that adaptation strategies could be used to compensate for 
task performance problems and thus improve ADL ability. The 
compensatory and educational models (12) were used 
as primary means to teach the participants how to 
adapt more successfully, i.e. how to solve ADL task 
performance problems by implementing adaptation 
VWUDWHJLHVVXFKDVDVVLVWLYHGHYLFHVPRGL¿FDWLRQVRI
$'/WDVNVDQGSK\VLFDODQGRUVRFLDOHQYLURQPHQWV
The sessions took place in a clinical ADL unit, i.e. a 
URRPÀDWXVHGWRREVHUYHDQGSUDFWLFH$'/WDVN
performance in a simulated, but naturalistic, home 
environment. 
ACTIVE programme. The ACTIVE programme (Ap-
SHQGL[,,ZDVGHYHORSHGDQGOHGE\DSK\VLRWKHUDSLVW
included 10 2-h sessions and aimed at improving 
ADL ability by means of graded physical activity 
(19, 20). This approach was based on the assump-
tion that increased physical activity improves body 
functions and structures and allows ADL tasks to be 
SHUIRUPHGDWDORZHUSHUFHQWDJHRIPD[LPXPFDSDFLW\
(7). Education was the primary means to implement 
strategies to increase physical activity in everyday 
life. The programme was conducted in a clinical unit 
¿WWHGIRUJURXSGLVFXVVLRQVDQGSHUIRUPDQFHRIOLJKW
H[HUFLVHVHJUHVLVWDQFHEDQGH[HUFLVHVFig. 1. IMPROvE study design for phase I and phase II.
Inclusion
Total group(n=192)
2-weeks interdisciplinary
rehabilitation program
Group A (n=96)
6-months waiting list 
control
Group B (n=96)
pre-intervention assessment
pre-intervention assessment (A1)
2-weeks interdisciplinary
rehabilitation program 
Group (n=96)
16-weeks ADAPT program 
Group (n=48)
16-weeks ACTIVE program 
Group (n=48)
4-weeks post-intervention assessment (A3)
Phase I
Phase II
pre-post intervention assessment (A2)
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Procedures 
The study included 3 assessments points. Baseline assessment 
1 (A1) was performed 3 weeks prior to the interdisciplinary re-
KDELOLWDWLRQSURJUDPPH7KHUHZDVDSSUR[LPDWHO\PRQWKEHW-
ween the end of the interdisciplinary rehabilitation programme 
and the beginning of the additional programmes. Assessment 2 
(A2) was performed 3 weeks after the rehabilitation programme, 
and served as a baseline prior to entry to the additional program-
mes. For logistical reasons, assessment 3 (A3) was performed 4 
ZHHNVDIWHUWKHDGGLWLRQDO$'$37$&7,9(SURJUDPPHV)LJ
1). While the primary endpoint was change during the interdis-
ciplinary rehabilitation programme and additional ADAPT or 
$&7,9(SURJUDPPHV$±$WKHVHFRQGDU\HQGSRLQWZDV
FKDQJHGXULQJWKHDGGLWLRQDOSURJUDPPHV$±$
Primary outcome
Change in observed ADL ability was the primary outcome 
measured with the Assessment of Motor and Process Skills 
(AMPS) (21). 
Assessment of Motor and Process Skills (AMPS). The AMPS 
evaluates 2 aspects of ADL ability; ADL motor ability (amount 
RIHIIRUWIDWLJXHDQGRUFOXPVLQHVVDQG$'/SURFHVVDELOLW\
(degree of disorganization, inappropriate use of time, space 
RUREMHFWVDQGDGDSWLQJDFWLRQV7KHTXDOLW\RI$'/
motor skills (move self and objects) and 20 ADL process skills 
(organize and adapt actions) is scored on a 4-point ordinal 
VFDOH LQ WHUPVRI HDVH HI¿FLHQF\ VDIHW\ DQG LQGHSHQGHQFH
Raw scores are analysed using a many-faceted Rasch-based 
computer-scoring software program, which converts the raw 
ordinal scores into 2 overall linear measures of ADL motor 
DQG$'/SURFHVVDELOLW\H[SUHVVHGLQORJLWVLH ORJLVWLFDOO\
transformed probability units) adjusted for rater severity as 
ZHOODV$'/WDVNDQGVNLOOLWHPGLI¿FXOW\%RWKWKH$036
ADL motor ability measure and the AMPS ADL process ability 
measure served as primary outcomes in this study. ADL ability 
measures below the 1.50 logit independence cut-off on the ADL 
motor scale and below the 1.00 logit independence cut-off on 
the ADL process scale indicate a likely need for assistance (21). 
Measures below the lower independence cut-offs of 1.00 and 
0.70 logits for ADL motor and ADL process ability, respectively, 
PDUNDQHHGIRUPRGHUDWHPD[LPDODVVLVWDQFH7KH$036
has demonstrated sound psychometric properties when applied 
WRZRPHQZLWK¿EURP\DOJLD LQFOXGLQJVHQVLWLYLW\ WRFKDQJH
post-intervention (23). According to the AMPS manual (21) a 
difference of ORJLWVRQWKH$'/PRWRUDQGRU$'/SURFHVV
VFDOHVGH¿QHVDFOLQLFDOO\UHOHYDQWGLIIHUHQFHLQ$'/DELOLW\
Secondary outcomes
Secondary outcomes included self-reported ADL ability eva-
luated with the ADL-Questionnaire (ADL-Q) (24) and the 
physical functioning subscale of the MOS 36-item Short Form 
(25) (SF-36 PF). Disease severity was evaluated with the total 
score of the Fibromyalgia Impact Questionnaire (FIQ) (26) and 
SDLQZLWKWKH),4SDLQVXEVFDOH+HDOWKUHODWHGTXDOLW\RIOLIH
was evaluated with the SF-36 Physical Composite Score (PCS) 
and Mental Composite Score (MCS) (25).
ADL-Questionnaire (ADL-Q). ADL-Q is a standardized instru-
PHQWGHYHORSHGWRPHDVXUHDSHUVRQ¶VSHUFHLYHGTXDOLW\RI$'/
task performance in 12 domains related to 47 ADL tasks. The 
SHUVRQPDUNVWKHTXDOLW\RIWKH$'/WDVNSHUIRUPDQFHXVLQJ
UHVSRQVHFDWHJRULHVUHÀHFWLQJHI¿FLHQF\HIIRUWIDWLJXHVDIHW\
DQGLQGHSHQGHQFH$'/4UHTXLUHV5DVFKPHDVXUHPHQWPHW-
hods in order to convert the raw ordinal data into linear measures 
of ADL ability (24, 27). The ADL-Q has demonstrated sensiti-
YLW\WRFKDQJHZKHQDSSOLHGLQZRPHQZLWK¿EURP\DOJLD
Clinically relevant differences were determined based on the 
criterion of 0.5 standard deviation (SD) (28) for a comparable 
VWXG\VDPSOHLHORJLWV
MOS 36-Item Short Form (SF-36). The SF-36 is a generic instru-
ment constructed to evaluate physical and mental health-related 
TXDOLW\RIOLIHH[SUHVVHGLQFRPSRVLWHVFRUHVLH6)3&6
and SF-36 MCS. The ordinal scale scores are transformed into 
OLQHDUVFDOHVUDQJLQJIURPWRDQGVWDQGDUGL]HGWRUHÀHFW
a general population (US) mean of 50 (SD 10). Measures of 0 
= worst possible health status, and 100 = best health status. The 
6)3)VXEVFDOHHYDOXDWHVWKHH[WHQWRISHUFHLYHGOLPLWDWLRQV
of task performance due to health-related problems (i.e. perform 
vigorous and moderate activities, lift or carry groceries, climb 1 
RUVHYHUDOÀLJKWVRIVWDLUVPDNHEHGVZDONEORFNRUPRUHWKDQ
1 mile, and bathe or dress). Response categories are scored on 
a 3-point Likert scale (i.e. 1 = limited to 3 = not limited at all). 
Raw scores are summed into 1 overall score for functioning, 
ranging from 0 to 100 points, in which 0 = severely limited and 
100 = the person performs all types of tasks (25). Based on the 
criterion of 0.5 SD (28) in a comparable study sample (30), clini-
cally relevant differences were determined as: SF-PF 10.00 
points, SF-36 PCS 3.34 points and SF-36 MCS > 5.98 points. 
Fibromyalgia Impact Questionnaire (FIQ). FIQ is a disease-
VSHFL¿FTXHVWLRQQDLUHFRPSRVHGRIVXEVFDOHVGHVLJQHGWR
evaluate disease severity (FIQ total). The average person with 
¿EURP\DOJLDLVH[SHFWHGWRREWDLQD),4WRWDOVFRUHRIDSSUR[-
imately 50 points, whereas more severely impacted persons 
VFRUH!RXWRI7KH¿IWKLWHPLQWKH),4LVDPP
visual analogue scale (VAS) used to evaluate pain intensity; 0 
= no pain to 10 = very severe pain (26). Based on the criterion 
of 0.5 SD (28) in a comparable study sample (30), clinically 
relevant differences were determined as: FIQ total 9.27 points 
and FIQ pain > 0.98 mm.
Statistical and responder analyses
Sample size was based on the sample size calculation from 
SKDVH ,,0352Y( :LWK$036 DV SULPDU\ RXWFRPH D
2-sample pooled t-test of a normal mean difference with a 
VLGHG VLJQL¿FDQFH OHYHO RI  DVVXPLQJ D FRPPRQ6'
RIDVDPSOHVL]HRISHUJURXSZDVUHTXLUHGWRREWDLQD
power of at least 0.9 to detect a group mean difference of 0.2 
(6). Because participants would be enrolled in groups of 8 it was 
decided to include 96 participants in each arm, thus including 
DWRWDORISDUWLFLSDQWVLQSKDVH,,0352Y()LJ7KLV
VDPSOHVL]HFDOFXODWLRQDOORZHGIRUDQH[SHFWHGGURSRXWUDWH
RILQSKDVH,,,0352Y((I¿FDF\ZDVDQDO\VHGRQDSHU
protocol basis, only including participants with an attendance 
of at least 25% in the additional programmes. Participants 
who withdrew or attended less than 25% were not reassessed 
ZHHNVSRVWLQWHUYHQWLRQ&RQVHTXHQWO\QRLQWHQWLRQWRWUHDW
analyses were performed. Distribution of data was tested for 
normality. Primary outcomes, i.e. AMPS ADL ability measu-
res, were investigated using analyses of variance (ANOVA) 
ZLWK WLPH $$$ E\ SURJUDPPH $'$37$&7,9(
as repeated measure, followed by post hoc paired-samples 
and independent-samples t-tests, and reported as means and 
FRQ¿GHQFH LQWHUYDOV &, DW WKHSULPDU\ $±$
DQGVHFRQGDU\HQGSRLQWV$±$6HFRQGDU\RXWFRPHVZHUH
analysed at the primary endpoint. Changes in the linear ADL-Q 
J Rehabil Med 49, 2017
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measures were analysed and compared using paired-samples and 
independent-samples t-tests, while changes in the ordinal SF-36 
DQG),4VFRUHVZHUHDQDO\VHGDQGFRPSDUHGXVLQJ:LOFR[RQ
VLJQHGUDQN WHVW DQG0DQQ±:KLWQH\U test and reported in 
PHGLDQVDQGTXDUWLOHV4
5HVSRQGHUVZHUHGH¿QHGDVSDUWLFLSDQWVDFKLHYLQJDFOLQLFDOO\
relevant improvement in ADL ability measures on instruments 
VSHFL¿FDOO\GHVLJQHGWRPHDVXUH$'/DELOLW\ LH WKH$036
 ORJLWV DQG$'/4  ORJLWV7KH SURSRUWLRQV
(number and percentages) of responders were calculated and 
FRPSDUHGE\3HDUVRQ¶VȤ2 tests and mean 
changes in observed and self-reported 
ADL ability for responders were analysed 
and compared using paired-samples and 
independent-samples t-tests and reported 
in means and 95% CI. SPSS software was 
used in all analyses (32).
RESULTS
Recruitment and participants’ 
characteristics
Overall, 85 participants were en-
rolled in the interdisciplinary re-
habilitation programme and were 
TXDVLUDQGRPL]HG WR WKH$'$37
(n = 43) or ACTIVE (n = 42) pro-
JUDPPHV)LJLOOXVWUDWHVWKHÀRZ
of participants through the study, 
including time points and reasons 
for the large dropout (n = 37). Base-
line characteristics for participants 
completing the ADAPT or ACTIVE 
programmes and participants who 
withdrew are presented in Table I. 
In all 3 groups, the pain duration 
averaged 10 years and participants 
reported high levels of pain and fati-
gue. ADL ability measures indicated 
considerable disability, 72% were 
unemployed, and 44% had a pending social welfare 
DSSOLFDWLRQ1R VLJQL¿FDQW GLIIHUHQFHV LQ EDVHOLQH
FKDUDFWHULVWLFVEHWZHHQWKHJURXSVZHUHLGHQWL¿HG
Primary outcomes at primary and secondary endpoints
&KDQJHV RYHU WKH  DVVHVVPHQW SRLQWV $±$ LQ
primary outcomes, i.e. AMPS ADL motor and process 
Fig. 2. &216257 ÀRZ GLDJUDP VKRZLQJ SDUWLFLSDQWV¶ ÀRZ WKURXJK WKH VWXG\ $ $ $
assessments 1, 2, 3.
Baseline assessments (A1) (n=85) 
Assessed at A3 and included in the per 
protocol analysis (n=21) 
!
Lost to four-week follow-up (n=0) 
Allocated to ADAPT program (n=43) 
Total withdrawers (n=22) 
Withdrew from the interdisciplinary    
   rehabilitation program and consequently    
   not assessed at A2 (n=3) 
Withdrew prior to ADAPT (n=15) due to 
- Could not incorporate the program into 
life situation (energy/work/family) (n=7) 
- Transportation (n=5) 
- Family issues (n=1) 
- Could not be contacted (n=1) 
- Not motivated for the program (n=1) 
Attended ADAPT <25% (n=4)  
Lost to four-week follow-up (n=0) 
Allocated to ACTIVE program (n=42) 
Total withdrawers (n=15) 
Withdrew from the interdisciplinary    
   rehabilitation program and consequently  
   not assessed at A2 (n=3) 
Withdrew prior to ACTIVE (n=9) due to 
- Could not be contacted (n=5) 
- Transportation (n=3) 
- Health related issues (n=1) 
Attended ACTIVE <25% (n=3)  
Assessed at A3 and included in the per 
protocol analysis (n=27)
Allocation 
Analysis 
Follow-Up 
Quasi-randomization (n=85)   
Enrollment 
Enrolled into the interdisciplinary 
rehabilitation program (n=85) 
Table I. Baseline characteristics for the total sample and when grouped into ADAPT participants, ACTIVE participants and withdrawers
Variables (A1) Total (n = 85) ADAPT (n = 21) ACTIVE (n = 27) Withdrawers (n = 37)
Age, years, mean (95% CI) 45.3 (42.8–47.7) 43.4 (38.8–49.0) 44.7 (40.2–49.1) 47.0 (43.4–50.5)
Duration of pain, years, mean (range) 10.0 (5–15) 10.0 (5–15) 9.5 (5–16) 9.5 (4–15)
Tender point count, medians (IQR) 18 (18–18) 18 (18–18) 18 (18–18) 18 (18–18)
Unemployed due to the pain condition, n (%) 61 (72) 18 (86) 19 (70) 24 (65)
Pending social welfare application, n (%) 37 (44) 12 (57) 9 (33) 16 (43)
AMPS ADL motor, mean (95% CI) 1.15 (1.05–1.26) 1.13 (0.97–1.29) 1.10 (0.91–1.28) 1.21 (1.01–1.40)
AMPS ADL process, mean (95% CI) 0.90 (0.84–0.96) 0.83 (0.72–0.95) 0.90 (0.80–1.00) 0.93 (0.81–1.05)
ADL-Q, mean (95% CI) 2.18 (1.78–2.63) 2.26 (1.44–3.22) 2.14 (1.47–2.88) 2.17 (1.43–2.96)
SF-36 PF, median (IQR) 40.0 (25–55) 35.0 (23–40) 45.0 (30–60) 45.0 (21–55)
SF-36 PCS, median (IQR) 26.9 (22–32) 24.4 (20–28) 28.0 (23–32) 27.8 (22–34)
SF-36 MCS, median (IQR) 38.8 (31–49) 38.8 (30–50) 41.3 (36–51) 37.8 (28–45)
FIQ total, median (IQR) 64.1 (55–74) 64.1 (55–74) 59.1 (53–70) 63.9 (58–77)
FIQ pain, median (IQR) 7.7 (6–9) 7.8 (6–9) 7.6 (6–8) 7.7 (6–9)
FIQ fatigue, median (IQR) 9.1 (8–10) 9.2 (8–10) 8.6 (7–10) 9.1 (8–10)
$'$37DGDSWDWLRQSURJUDPPH$&7,9(SK\VLFDODFWLYLW\SURJUDPPH&,FRQ¿GHQFHLQWHUYDO,45LQWHUTXDUWLOHUDQJH$036$VVHVVPHQWRI0RWRUDQG
Process Skills; ADL: activities of daily living; ADL-Q: ADL-Questionnaire; SF-36: MOS 36-item Short Form; SF-36-PF: Physical Functioning; SF-36 MCS: Mental 
Composite Score; SF-36 PCS: Physical Composite Score; FIQ: Fibromyalgia Impact Questionnaire; A1: Assessment 1.
www.medicaljournals.se/jrm
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245,PSURYLQJ$'/DELOLW\LQZRPHQZLWK¿EURP\DOJLD
DELOLW\PHDVXUHVDUH LOOXVWUDWHGLQ)LJD±E,PSUR-
vements in ADL motor ability in the ADAPT (mean 
change = 0.43; 95% CI = 0.31 to 0.56) and ACTIVE 
(mean change = 0.34; 95% CI = 0.17 to 0.52) groups 
from baseline (A1) to 4-week follow-up (A3) were sta-
WLVWLFDOO\VLJQL¿FDQWDQGFOLQLFDOO\UHOHYDQWEXWZLWKRXW
VLJQL¿FDQWGLIIHUHQFHVDFURVVJURXSV&, ±
to 0.32) (Table II). In addition, the ADL process ability 
LPSURYHGVWDWLVWLFDOO\VLJQL¿FDQWLQWKH$'$37PHDQ
change = 0.33; 95% CI = 0.22 to 0.43) and ACTIVE 
(mean change = 0.25; 95% CI = 0.12 to 0.38) groups 
at the primary endpoint, but only the improvement in 
the ADAPT group was clinically relevant and there 
ZHUHQRVLJQL¿FDQWJURXSGLIIHUHQFHV&, ±
to 0.25) (Table II). 
$WWKHVHFRQGDU\HQGSRLQW$±$LHSULRUWRWKH
additional programmes (A2) to 4-week follow-up (A3), 
WKH$'/PRWRUDELOLW\LPSURYHGVWDWLVWLFDOO\VLJQL¿FDQW
in the ADAPT group (mean change = 0.25: 95% CI 
= 0.13 to 0.37), but not in the ACTIVE group (mean 
FKDQJH &, ±WR7KHGLIIHUHQFH
EHWZHHQJURXSVZDVVWDWLVWLFDOO\VLJQL¿FDQW&,
 WR7DEOH,,1RVLJQL¿FDQWFKDQJHV LQ
ADL process ability in either of the groups (ADAPT: 
mean change = 0.07; 95% CI = 0.00 to 0.15; ACTIVE: 
PHDQFKDQJH &, ± WRZHUH
observed at this assessment point (Table II). 
Secondary outcomes at primary endpoint
While the ADAPT group reported no significant 
change in ADL ability evaluated with ADL-Q (mean 
FKDQJH ±&, ±WRWKH$&7,9(
JURXSUHSRUWHGVWDWLVWLFDOO\VLJQL¿FDQWORZHUOHYHOVRI
$'/DELOLW\PHDQFKDQJH ±&, ±
WR ±7KLV REVHUYHGGHFOLQH KRZHYHUZDVQRW
clinically relevant and differences between groups in 
$'/4$'/DELOLW\ZDVQRWVWDWLVWLFDOO\VLJQL¿FDQW
(p = 0.47) (Table II). None of the other self-reported 
VHFRQGDU\RXWFRPHV VKRZHGDQ\ VLJQL¿FDQW FKDQJH
over time or differences at group level (Table II). 
Fig. 3. (a) Mean changes in AMPS ADL motor ability over time. (b) 
Mean changes in AMPS ADL process ability over time. (A1, A2, A3) by 
programme (ADAPT/ACTIVE). ADAPT: adaptation programme; ACTIVE: 
physical activity programme; AMPS: Assessment of Motor and Process 
Skills; ADL: activities of daily living; A1, A2, A3: Assessment 1, 2, 3.
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Table II. Changes in primary outcomes at primary and secondary endpoints and secondary outcomes at primary endpoint
Variables ADAPT (n = 21) ACTIVE (n = 27) Group difference (95% CI)
Primary outcomes at primary endpoint (A1–A3)
AMPS ADL motor ability, mean (95% CI) 0.43 (0.31 to 0.56) 0.34 (0.17 to 0.52) 0.09 (–0.13 to 0.32)
AMPS ADL process ability, mean (95% CI) 0.33 (0.22 to 0.43) 0.25 (0.12 to 0.38) 0.07 (–0.11 to 0.25)
Secondary outcomes at primary endpoint (A1–A3) Group differences (p-value)
ADL-Q, mean (95% CI) –0.21 (–1.40 to 0.80) –0.63 (–1.13 to –0.16) (0.47)
SF-36 PF, median (IQR) 0.00 (–7.50 to 7.50) –5.00 (–12.50 to 10.00) (0.53)
SF-36 MCS, median (IQR) 3.84 (–3.24 to 10.87) 2.89 (–3.65 to 7.11) (0.61)
SF-36 PCS, median (IQR) –0.60 (–3.53 to 2.54) –1.82 (–7.18 to 3.64) (0.52)
FIQ total, median (IQR) 0.05 (–8.94 to 11.92) –1.06 (–8.00 to 9.32) (0.66)
FIQ pain, median (IQR) 0.20 (–0.80 to 0.80) 0.75 (–0.90 to 1.43) (0.38)
Primary outcome at secondary endpoint (A2–A3) Group difference (95% CI)
AMPS ADL motor ability, mean (95% CI) 0.25 (0.13 to 0.37) 0.04 (–0.07 to 0.15) 0.21 (0.03 to 0.39)
AMPS ADL process ability, mean (95% CI) 0.07 (0.00 to 0.15) 0.07 (–0.01 to 0.15) 0.00 (–0.11 to 0.12)
$'$37DGDSWDWLRQSURJUDPPH$&7,9(SK\VLFDODFWLYLW\SURJUDPPH&,FRQ¿GHQFHLQWHUYDO,45LQWHUTXDUWLOHUDQJHV$036$VVHVVPHQWRI0RWRU
and Process Skills; ADL: activities of daily living; ADL-Q: ADL-Questionnaire; SF-36: MOS 36-item Short Form; SF-36-PF: Physical Functioning; SF-36 MCS: Mental 
Composite Score; SF-36 PCS: Physical Composite Score; FIQ: Fibromyalgia Impact Questionnaire; A1, A2, A3: Assessment 1, 2, 3. 
6WDWLVWLFDOO\VLJQL¿FDQWGLIIHUHQFHVDUHPDUNHGLQLWDOLFDQGFOLQLFDOO\UHOHYDQWLPSURYHPHQWVDUHPDUNHGLQEROG
J Rehabil Med 49, 2017
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246 C. von Bülow et al.
Responder analyses
5HVSRQGHUDQDO\VHVUHYHDOHGWKDWRIWKH
total sample obtained clinically relevant improvements 
in ADL motor ability (mean change = 0.60; 95% CI 
 WRDQGLQ$'/SURFHVVDELOLW\
(mean change = 0.53; 95% CI = 0.47 to 0.61) at the 
SULPDU\HQGSRLQW6L[W\VHYHQSHUFHQWLQWKH
ADAPT group showed clinically relevant improve-
ments in ADL motor ability (mean change = 0.58; 95% 
&, WRDQGLQ$'/SURFHVV
ability (mean change = 0.52; 95% CI = 0.43 to 0.59). 
,QFRPSDULVRQLQWKH$&7,9(JURXSVKR-
wed clinically relevant improvements in ADL motor 
ability (mean change = 0.62; 95% CI = 0.47 to 0.77) 
DQGLQ$'/SURFHVVDELOLW\PHDQFKDQJH
= 0.55; 95% CI = 0.45 to 0.67) at the primary endpoint. 
Measures at the secondary endpoint showed that 71% 
RIWKH$'$37UHVSRQGHUVDQGRI
the ACTIVE responders gained their ADL motor abi-
lity improvements during the additional programmes. 
&RUUHVSRQGLQJO\DQGRIWKH
responders gained their ADL process ability improve-
ments during the ADAPT and ACTIVE programmes, 
respectively. Neither the proportion of responders 
nor the mean improvements in ADL ability differed 
VWDWLVWLFDOO\VLJQL¿FDQWEHWZHHQJURXSVDWSULPDU\RU
secondary endpoints (Table III). 
6XEJURXSDQDO\VLVVKRZHGWKDWLQ$'$37$&7,9(
responders the mean ADL motor ability measure was 
0.91 (95% CI =0.78 to 1.04) logits and the mean ADL 
process ability measure 0.68 (95% CI = 0.61 to 0.75) 
logits at baseline (A1). These ability measures were 
FOLQLFDOO\ DQG VWDWLVWLFDOO\ VLJQL¿FDQWO\ ORZHU $'/
motor mean difference = 0.58; 95% CI = 0.43 to 0.74: 
ADL process mean difference = 0.47; 95% CI = 0.36 
to 0.59) than baseline measures for the non-responders 
(ADL motor ability = 1.45; 95% CI = 1.28 to 1.61: ADL 
process ability = 1.05; 95% CI = 0.96 to 1.13). 
$WRWDORI UHSRUWHGFOLQLFDOO\ UHOHYDQW
improvements (mean change = 2.50; 95% CI = 1.45 
to 4.33) in ADL ability at the primary endpoint on 
WKH$'/4ZKLOHUHSRUWHGQRFOLQLFDOO\
UHOHYDQWFKDQJHPHDQFKDQJH ±&, ±
WR±
DISCUSSION
7RRXU NQRZOHGJH WKLV LV WKH¿UVW VWXG\ WR H[SORUH
changes in ADL ability and compare the ADL ability 
outcomes of individually tailored add-on adaptation 
or graded physical activity programmes following an 
interdisciplinary rehabilitation programme in women 
ZLWK¿EURP\DOJLD7KHUHVXOWVRIWKLVH[SORUDWRU\VWXG\
indicated that participants achieved statistically signi-
¿FDQWLPSURYHPHQWVLQ$'/PRWRUDQG$'/SURFHVV
ability at 4-week post-intervention independent of 
group allocation to the ADAPT vs the ACTIVE pro-
gramme. Although responder analyses demonstrated 
inter-individual patient variability, clinically relevant 
improvements in ADL motor and ADL process ability 
were observed in 63% and 48% of the overall study 
sample, respectively. No previous studies have shown 
similar functional responder rates among women with 
¿EURP\DOJLD
,QSKDVH,,0352Y(HYDOXDWLQJWKHRXWFRPHV
of the interdisciplinary rehabilitation programme, 
36% of the participants obtained clinically relevant 
improvements in ADL motor ability and 18% in ADL 
Table III. Proportion of responder and mean changes in activities of daily living (ADL) ability at primary and secondary endpoints
Variables ADAPT ACTIVE Group differences
Responders on primary outcome at primary endpoint (A1–A3)
AMPS ADL motor ability, n (%) 14 (67) 16 (59) Ȥ2= 0.28; df= 1; p = 0.60
Change, mean (95% CI) 0.58 (0.48–0.71) 0.62 (0.47–0.77) –0.03 (–0.24 to 1.18)
Ability at A1, mean (SD) 0.99 (0.80–1.19) 0.85 (0.67–1.04) 0.14 (–0.14 to 0.43)
AMPS ADL process ability, n (%) 11 (52) 12 (44) Ȥ2 = 0.30; df= 1; p = 0.59
Change, mean (95% CI) 0.52 (0.43–0.59) 0.55 (0.45–0.67) –0.03 (–0.19 to 0.12)
Ability at A1, mean (95% CI) 0.64 (0.58–0.72) 0.71 (0.59–0.82) –0.07 (–0.22 to 0.09)
ADL-Q ADL ability, n (%) 2 (10) 3 (11) Ȥ2= 0.02; df= 1; p = 0.89
Change, mean (95% CI) 4.00 (2.09–5.93) 1.51 (1.14–1.81) 2.49 (–2.16 to 7.14)
Ability at A1, mean (95% CI) 1.53 (1.21–1.85) 1.53 (0.51–3.25) 0.01 (–3.64 to 3.65)
Responders on primary outcome at secondary endpoint (A2–A3)
AMPS ADL motor ability, n (%) 10 (48) 8 (30) Ȥ2= 1.63; df= 1; p = 0.20
Change, mean (95% CI) 0.51 (0.43–0.59) 0.46 (0.38–0.53) 0.06 (–0.09 to 0.19)
Ability at A2, mean (95% CI) 1.11 (0.96–1.23) 1.28 (1.10–1.41) 0.17 (–0.41 to 0.07)
AMPS ADL process ability, n (%) 2 (10) 3 (11) Ȥ2= 0.03; df= 1; p = 0.86
Change, mean (95% CI) 0.37 (0.35–0.39) 0.46 (0.39–0.51) –0.09 (–0.25 to 0.07)
Ability at A2, mean (95% CI) 0.86 (0.74–0.97) 0.77 (0.66–0.89) 0.08 (–0.30 to 0.47)
$'$37DGDSWDWLRQSURJUDPPH$&7,9(SK\VLFDODFWLYLW\SURJUDPPH&,FRQ¿GHQFHLQWHUYDO,45LQWHUTXDUWLOHUDQJHV$036$VVHVVPHQWRI0RWRUDQG
Process Skills; ADL-Q: ADL-Questionnaire; SF-36: MOS 36-item Short Form; SF-36-PF: Physical Functioning; SF-36 MCS: Mental Composite Score; SF-36 PCS: 
Physical Composite Score; FIQ: Fibromyalgia Impact Questionnaire; A1, A2, A3: Assessment 1, 2, 3. Responders on the AMPS had changed > 0.3 logits in ADL 
motor and/or ADL process ability. Responders on the ADL-Q had changed > 1.00 logits.
www.medicaljournals.se/jrm
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247,PSURYLQJ$'/DELOLW\LQZRPHQZLWK¿EURP\DOJLD
process ability, respectively. Thus, adding additional 
programme components to the rehabilitation pro-
JUDPPHZKLFKZHUHVSHFL¿FDOO\GHYHORSHGWRLPSURYH
ADL ability, seems to have improved functional gains 
considerably, even in this sample of women with 
¿EURP\DOJLD SUHVHQWLQJZLWK VXEVWDQWLDO GLVDELOLW\
established over many years. 
Assessed with the AMPS, the observed performance 
GLI¿FXOWLHV LQ RXU VWXG\ VDPSOHZHUH GRPLQDWHGE\
decreased ADL motor ability and it was within this 
domain that most participants achieved a clinically 
meaningful improvement. The study revealed no sig-
QL¿FDQWGLIIHUHQFHVEHWZHHQWKH$'$37DQG$&7,9(
groups in ADL motor ability outcome at the primary 
HQGSRLQWVXJJHVWLQJHI¿FLHQF\RIERWKSURJUDPPHV
However, the observed larger mean change in ADL 
motor ability and a 95% CI indicating a clinically re-
levant improvement in the majority of participants in 
the ADAPT group, could indicate that this programme 
was superior to the ACTIVE programme. Overall, the 
participants attending the ADAPT programme obtai-
ned a mean change of 0.43 (95% CI = 0.31 to 0.56) 
logits in ADL motor ability vs 0.34 (95% CI = 0.17 to 
0.52) logits in the ACTIVE programme. Although not 
VLJQL¿FDQWWKHQRWLRQRIDEHWWHU$'/PRWRUDELOLW\
outcome in the ADAPT programme was further sup-
ported by a higher proportion of ADL motor responders 
in this group, 48% vs 30% in the ACTIVE group. This 
could indicate that participants in the ACTIVE group 
had more differential treatment effects compared with 
SDUWLFLSDQWVLQWKH$'$37JURXSSRVVLEO\UHÀHFWLQJ
problems with adherence. Adherence constitutes a 
NQRZQSUREOHPLQ¿EURP\DOJLDDVSK\VLFDODFWLYLW\
PD\EH H[SHULHQFHG WR LQFUHDVH V\PSWRPV 7KH
seemingly less differential treatment response and 
higher responder rate in the ADAPT group may support 
a broader relevance of applying adaptation strategies 
to improve ADL ability in women with moderate to 
VHYHUH¿EURP\DOJLD$GDSWDWLRQPD\EHDQHDVLHUDQG
better tolerated approach and may therefore promote 
adherence. This hypothesis, however, needs testing in 
future larger studies.
Post hocVXEJURXSDQDO\VLVUHYHDOHGVLJQL¿FDQWED-
VHOLQH$GLIIHUHQFHVLQWKH$036$'/SUR¿OHVRI
responders and non-responders. At baseline, the non-
responders presented with overall higher levels of ADL 
DELOLW\ LH WKH\XVHGOHVVHIIRUWZHUHPRUHHI¿FLHQW
safe and independent during ADL task performance 
compared with responders. Responders presented with 
ADL ability measures below the lower independence 
cut-offs at baseline, indicating increased effort, fati-
gue, inappropriate use of time, space or objects and 
GHFUHDVHGDELOLW\WRDGDSWDFWLRQVHI¿FLHQWO\GXULQJ$'/
WDVNSHUIRUPDQFH7KHREVHUYHGH[WHQWRISHUIRUPDQFH
problems probably caused these participants to have 
DQHHG IRUPRGHUDWHPD[LPDO DVVLVWDQFH LQHYHU\GD\
life prior to entering the intervention (21). At 4-week 
post-intervention the obtained AMPS ADL ability 
measures in the responders indicated that ADL tasks 
ZHUHSHUIRUPHGZLWKVLJQL¿FDQWO\OHVVHIIRUWLQFUHDVHG
HI¿FLHQF\OHVVVDIHW\ULVNDQGOHVVQHHGRIDVVLVWDQFH
7KHVH¿QGLQJVDUHLQDFFRUGDQFHZLWKH[LVWLQJJXLGHOL-
nes, recommending interdisciplinary rehabilitation for 
more severely impacted persons (4, 5). The results of this 
study, however, seem to support the relevance of offering 
additional targeted interventions, as the majority of the 
participants gained their improvements in ADL motor 
DELOLW\GXULQJWKHDGGLWLRQDOSURJUDPPHV$±$
Despite the observed clinically relevant improve-
ments in AMPS ADL ability measures among a rather 
large proportion of the participants, only 10% reported 
clinically relevant improvements in ADL ability using 
the ADL-Q. Several studies (24, 33, 34) support that 
self-report and observation provides distinct informa-
tion about ADL ability and cannot substitute for each 
other. Individuals’ perception of functioning seems to 
EHLQÀXHQFHGE\IDFWRUVVXFKDVGLVHDVHVHYHULW\SDLQ
DQGKHDOWKUHODWHGTXDOLW\RIOLIHDQGPD\WKHUHIRUHQRW
UHÀHFWDFWXDOSHUIRUPDQFH$VQRQHRIWKHVHIDF-
tors changed during the intervention the participants’ 
UHSRUWLQJPD\VWLOOEHLQÀXHQFHG7KHODFNRIFKDQJHV
LQGLVHDVHVHYHULW\SDLQDQGKHDOWKUHODWHGTXDOLW\RI
life suggests that assessments at the body level and 
global assessments, cannot substitute for observation-
based evaluation of ADL ability (34). 
The study had several limitations. Due to the study 
design, with no control group, it was only possible to 
evaluate the ADL ability outcome of the combined 
intervention and not of the individual ADAPT and 
ACTIVE programmes. Still, it seems that the additional 
SURJUDPPHVVLJQL¿FDQWO\HQKDQFHGWKHSURSRUWLRQRI
UHVSRQGHUV7KHVWXG\ LQFOXGHGRQO\PRGHUDWHO\VH-
YHUHO\LPSDFWHGZRPHQZLWK¿EURP\DOJLDDQG¿QGLQJV
may therefore not be generalized to the overall referral 
population. A large proportion of the sample withdrew 
SULRUWRWKH$'$37$&7,9(SURJUDPPHVKRZHYHU
the reasons for dropping out were not adverse events, 
as reported previously (7, 8). The resulting smaller 
sample size, the lack of intention-to-treat analysis and 
per protocol analysis may have increased the risk of 
overestimating outcomes, whereas the use of blinded 
assessors is considered to reduce reporting bias (35). 
The small sample size may also have underpowered the 
study to identify changes in secondary outcomes and 
differences between groups, and future larger studies 
are therefore warranted. 
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In conclusion, although limited by a large dropout 
rate, the study showed that both adaptation and phy-
sical activity programmes following interdiscipli-
nary rehabilitation improved observed ADL ability, 
DVLQGLFDWHGE\GHFUHDVHGHIIRUWLQFUHDVHGHI¿FLHQF\
safety and independence. These improvements were 
LGHQWL¿HGLQPRUHWKDQWZRWKLUGVRIDVDPSOHRIZR-
PHQZLWK¿EURP\DOJLDSUHVHQWLQJZLWKORQJVWDQGLQJ
pain and substantial ADL disability at baseline. No 
VLJQL¿FDQW JURXS GLIIHUHQFHVZHUH REVHUYHG LQ WKLV
VPDOOHU VWXG\ VDPSOH LQGLFDWLQJ HI¿FLHQF\ RI ERWK
programmes. Still, the study pointed towards less dif-
ferential treatment response and higher responder rate 
in participants allocated to adaptation. Thus, the results 
RIWKLVH[SORUDWRU\VWXG\SURYLGHLQLWLDOHYLGHQFHIRU
using adaptation to improve ADL ability in women 
ZLWK¿EURP\DOJLDDQGVXSSRUWH[LVWLQJUHFRPPHQGD-
tions (7, 8) of integrating physical activity programmes 
LQWKHPDQDJHPHQWRI¿EURP\DOJLDSRSXODWLRQV
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Appendix I. Summary of the ADAPT programme
Objective ª7RWHDFKDQGVXSSRUWWKHSDUWLFLSDQWVLQGHYHORSLQJHI¿FLHQWDGDSWDWLRQVWUDWHJLHVWRLPSURYH$'/DELOLW\
Key elements » Identify ADL task performance problems (sessions 1–6) 
» Implement adaptation strategies to compensate for task performance problems (sessions 7–14)  
» Re-evaluate for enhanced and satisfying ADL task performance (sessions 15–16)
Session 1 » Introduction, the beginning of something new 
Presentation, group contract, clarify roles and expectations 
Session 2 » Prioritize roles and meaningful ADL tasks 
How roles are related to ADL tasks; identify important life roles and tasks perceived as crucial to that role 
Session 3 » Analyse ADL task performance 
How to analyse ADL task performance; observe participants perform ADL tasks and identify ineffective ADL skills (e.g. decreased ability 
to move or lift objects and/or decreased ability to organize and adapt performance); discuss which adaptation strategies that may 
compensate for ineffective ADL skills
Session 4 » Analyse ADL task performance (continued from session 3) 
Observe ADL task performance and identify ineffective ADL skills and relevant adaptation strategies
Session 5 » Clarify the causes to ADL task performance problems 
+RZ$'/WDVNSHUIRUPDQFHSUREOHPVDUHLQÀXHQFHGE\WKHWDVNWKHSHUVRQSHUIRUPLQJWKHWDVNDQGWKHHQYLURQPHQWLQZKLFKWKHWDVNLV
performed
Session 6 » Set goals and make a plan 
+RZWRGH¿QHDJRDOUHODWHGWR$'/WDVNSHUIRUPDQFHLGHQWLI\IDFWRUVWKDWPD\SURPRWHRUOLPLWWKHDFKLHYHPHQWVRIJRDOV
Session 7 » Use energy conservation principles to decrease effort during ADL task performance 
,QWURGXFHHQHUJ\FRQVHUYDWLRQSULQFLSOHVKRZGRHVHQHUJ\FRQVHUYDWLRQSULQFLSOHVLQÀXHQFH$'/WDVNSHUIRUPDQFH"
Session 8 ª3ODQHI¿FLHQW$'/WDVNSHUIRUPDQFH 
Introduction to assistive devices; plan and perform ADL tasks using adaptation strategies
Session 9 ª3ODQHI¿FLHQW$'/WDVNSHUIRUPDQFHFRQWLQXHGIURPVHVVLRQ 
Plan and perform ADL tasks using adaptation strategies
Session 10 » Apply for assistive devices 
How to apply for assistive devices in home community
Session 11 ª'RHVPRWLYDWLRQLQÀXHQFH$'/WDVNSHUIRUPDQFH" 
+RZGRHVPRWLYDWLRQLQÀXHQFH$'/WDVNSHUIRUPDQFHDQGKRZPD\PRWLYDWLRQIRUSHUIRUPLQJ$'/WDVNVWKDWDUHQHFHVVDU\WRSHUIRUPEH
enhanced?
Session 12 » Use ADL tasks to increase physical activity and improve body functions 
Can ADL task performance be categorized as physical activity? Observe ADL task performance and identify ADL skills (e.g. walk and lifts) 
that may improve body functions (e.g. endurance and strengths)
Session 13 » Performance of ADL tasks when having pain 
+RZPD\SDLQLQÀXHQFH$'/WDVNSHUIRUPDQFH",VWKHUHDOLQHDUFRUUHODWLRQEHWZHHQWKHOHYHORISDLQDQGWKHDELOLW\WRSHUIRUP$'/WDVNV"
Session 14 ª$GDSW$'/WDVNSHUIRUPDQFHWRÀXFWXDWLRQVLQ$'/DELOLW\ 
Specify how to perform ADL tasks on a day with less disease severity and how to perform ADL tasks on a day with high disease severity 
and identify tasks that may not need to be performed
Session 15 » Looking back, what did we do, and what did you learn? 
Create a group concept-map to organize and structure learning outcomes; which adaptation strategies have been implemented in ADL task 
performances and how have ADL task performance changed?
Session 16 » Evaluation, celebrating and looking forward 
Discuss future goals and plans 
ADAPT: adaptation programme; ADL: activities of daily living.
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Appendix II. ACTIVE programme
Objective » To teach and support the participants in increasing the level of physical activity in everyday life to improve ADL ability
Key elements » Identify individual training barriers 
» Individual goal-setting 
» Pacing principles 
Session 1 » Introduction, the beginning of something new 
Presentation, group contract, clarify roles and expectations 
Session 2 ª'H¿QHDJRDODQGUHDFKLW 
'H¿QHUHDOLVWLFDQGPHDQLQJIXOJRDOVSDFLQJSULQFLSOHVLHKRZWRHYDOXDWHSUHVHQWOHYHORISK\VLFDODELOLW\SULRUWREHLQJDFWLYHLQRUGHUWR
reduce pain exacerbations and exercise intolerance (20) 
Session 3 » Physical activity in practice 
How to minimize pain exacerbation and exercise intolerance during physical activity; try out different exercises with resistance bands, gym 
balls and exercise on mats as inspiration
Session 4 » Barriers for being physically active 
The need to change habits when wanting to become more physically active; what are the barriers to being physically active and which 
strategies may be used to overcome these barriers?
Session 5 » Pain, physical activity and managing pain 
Central sensitization and the difference between acute and chronic pain; how to manage pain when being physically active 
Session 6 » Mid-term evaluation 
5HÀHFWXSRQWKHNQRZOHGJHJDLQHGDQGWKHQHHGWRDGMXVWSHUVRQDOJRDOV
Session 7 » Motivation for physical activity in everyday life 
Which kind of physical activity increase level of energy and which kind decrease level of energy? What may increase motivation for being 
physically active in everyday life? 
Session 8 ª+RZKDVFKURQLFSDLQLQÀXHQFHG\RXUZD\RIEHLQJSK\VLFDODFWLYH" 
Which kind of physical activity did you enjoy in the past and which kind of physical activity do you perform now? Which kind of physical 
activity would you like to do in the future?
Session 9 » Organize time, energy and physical activity 
How do you match level of energy during the day to the level of physical activity?
Session 10 » Long-term goals – looking back and forward 
5HÀHFWXSRQNQRZOHGJHJDLQHGPRWLYDWLRQIRUEHLQJSK\VLFDOO\DFWLYHDQGKRZWRSURJUHVVWRZDUGVGHVLUHGJRDOV
ACTIVE: physical activity programme; ADL: activities of daily living.
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